Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | CONSUN PHARMA (01681): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
20.06. | CONSUN PHARMA (01681): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE | 1 | HKEx | ||
20.06. | CONSUN PHARMA (01681): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | - | HKEx | ||
CONSUN PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
20.06. | CONSUN PHARMA (01681): CHANGES IN COMPOSITION OF THE NOMINATION COMMITTEE | 2 | HKEx | ||
16.06. | CONSUN PHARMA (01681): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
13.06. | CONSUN PHARMA (01681): VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE PROGRAM UNDER THE REPURCHASE MANDATE | 1 | HKEx | ||
22.05. | CONSUN PHARMA (01681): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, 22 MAY 2025 | - | HKEx | ||
30.04. | CONSUN PHARMA (01681): VOLUNTARY ANNOUNCEMENT PROTECTED PRODUCT OF TRADITIONAL CHINESE MEDICINE | - | HKEx | ||
28.04. | CONSUN PHARMA (01681): 2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | 1 | HKEx | ||
28.04. | CONSUN PHARMA (01681): ANNUAL REPORT 2024 | 1 | HKEx | ||
28.04. | CONSUN PHARMA (01681): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | 1 | HKEx | ||
28.04. | CONSUN PHARMA (01681): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM | 2 | HKEx | ||
28.04. | CONSUN PHARMA (01681): NOTIFICATION LETTER TO SHAREHOLDERS - ANNUAL GENERAL MEETING | 1 | HKEx | ||
28.04. | CONSUN PHARMA (01681): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING | 1 | HKEx | ||
28.04. | CONSUN PHARMA (01681): NOTICE OF ANNUAL GENERAL MEETING | 2 | HKEx | ||
28.04. | CONSUN PHARMA (01681): (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (2) PROPOSED FINAL DIVIDEND, (3) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW ... | 1 | HKEx | ||
25.04. | CONSUN PHARMA (01681): VOLUNTARY ANNOUNCEMENT NOTICE OF APPROVAL FOR CLINICAL TRIAL FOR SK-09 TABLET | - | HKEx | ||
08.04. | CONSUN PHARMA (01681): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 2 | HKEx | ||
08.04. | CONSUN PHARMA (01681): APPOINTMENT OF DIRECTORS AND CHANGE OF COMPOSITION OF BOARD COMMITTEES | 2 | HKEx | ||
26.03. | CONSUN PHARMA (01681): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 | 6 | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TEVA | 14,300 | -0,35 % | Formycon vergibt Deutschland-Vertrieb von FYB202 an Teva-Sparte ratiopharm | Die Formycon AG hat eine Vereinbarung mit der Teva-Tochter ratiopharm geschlossen, die das Ustekinumab-Biosimilar FYB202 unter dem Namen Fymskina ab dem dritten Quartal 2025 in Deutschland vermarkten... ► Artikel lesen | |
SINOPHARM | 2,057 | +0,39 % | Dividendenbekanntmachungen (16.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AEGON LTD BMG0112X1056 - 0,19 EUR ALTAGAS LTD CA0213611001 0,315 CAD 0,2007 EUR ALTEN SA FR0000071946 - 1,5 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
QUANTUM BIOPHARMA | 20,200 | +9,19 % | Quantum Biopharma Ltd: Quantum Biopharma arranges private placement | ||
CSPC PHARMA | 0,855 | +1,23 % | CSPC PHARMA (01093): NOMINATION COMMITTEE - TERMS OF REFERENCE | ||
WUXI BIOLOGICS | 2,743 | +1,59 % | Aktie von WuXi Biologics büßt 3,05 Prozent ein (2,6755 €) | Am Aktienmarkt liegt der Anteilsschein von WuXi Biologics zur Stunde im Minus. Das Wertpapier kostete zuletzt 2,68 Euro. Im Wertpapierhandel hat sich heute die Aktie von WuXi Biologics zwischenzeitlich... ► Artikel lesen | |
OPKO HEALTH | 1,114 | -1,59 % | OPKO Health, Inc.: OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting | MIAMI and JERUSALEM, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX) ("Entera") today announced that new pharmacologic and pharmacokinetic in vivo... ► Artikel lesen | |
SHANGHAI FOSUN PHARMACEUTICAL | 1,821 | +2,77 % | Fosun Pharma prices $34.25M Nature's Sunshine share sale | ||
DR REDDYS | 13,000 | -0,76 % | Dr. Reddy's Laboratories Ltd.: Alvotech and Dr. Reddy's Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda (pembrolizumab) | Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide ("Alvotech"), and Dr. Reddy's Laboratories Ltd., (BSE:... ► Artikel lesen | |
GEDEON RICHTER | 25,500 | +2,00 % | Gedeon Richter Plc.: Long-term Commitment to Treating Endometriosis and Improving Women's Quality of Life - Gedeon Richter at the World Congress on Endometriosis | SYDNEY, May 28, 2025 /PRNewswire/ --
Gedeon Richter had a strong presence at the World Congress of Endometriosis held this year in Sydney, Australia between 21-24 May 2025. As a Platinum... ► Artikel lesen | |
BAYER | 26,975 | +2,64 % | EQS-PVR: Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Bayer Aktiengesellschaft
Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
23.06.2025... ► Artikel lesen | |
MERCK KGAA | 112,65 | +0,90 % | MilliporeSigma and "Abbott Elementary" Inspire Students' Curiosity With Hands-On STEM | NORTHAMPTON, MA / ACCESS Newswire / June 25, 2025 / Between September 2024 and April 2025, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, teamed up with... ► Artikel lesen | |
NOVO NORDISK | 58,70 | +0,09 % | Buy or Goodbye?: Hellofresh, Tesla, Novo Nordisk und Zalando - Die Analystenstimmen des Tages | © Foto: Steffen Trumpf/dpaHellofresh, Tesla, Novo Nordisk und Zalando: So bewerten Top-Analysten die Aktien. Ein Überblick.JPMorgan senkt das Kursziel für Hellofresh Die US-Bank JPMorgan hat das Kursziel... ► Artikel lesen | |
PFIZER | 20,665 | +0,02 % | Depot Verdoppler mit Künstlicher Intelligenz: Novo Nordisk, PanGenomic Health und Pfizer zünden 2025 den Profit-Turbo | Lauf BlackRock Health Sciences steht der globale Gesundheitssektor 2025 vor einem beispiellosen Aufschwung. Nach Jahren der Volatilität durch die Pandemie soll die Branche jetzt die höchsten Gewinnzuwächse... ► Artikel lesen | |
EYENOVIA | 10,960 | +38,91 % | Eyenovia launches validator node for Hyperliquid blockchain | ||
ROCKET LAB | 30,200 | -0,10 % | Rocket Lab Corporation: Rocket Lab to Launch Electron Mission for European Space Agency's Next-Generation Navigation System | Rocket Lab Corporation (Nasdaq: RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced it has been selected to launch a dedicated Electron mission... ► Artikel lesen |